Skip to main content

Table 3 Linear regression for outcome eGFR at twelve months among those who did not reach the endpoint of ESRD by twelve months using focal as the reference group

From: Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome

 

eGFR at 12 months (n = 57)

 

β

p-value

eGFR at biopsy

0.35

<0.001

Age at biopsy (years)

-0.52

0.003

Crescentic class

-11.35

0.092

Mixed class

-21.25

0.001

Sclerotic class

-23.67

0.006

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us